MD | Medical Science Partner | Neuroscience & Rare Diseases, Hematology | 10+ Clinical Trials Investigator | 5+ years of clinical experience
Gene therapy is currently far from perfect, and one of the main concerns remains the safety of using these treatments. Patients who have undergone gene therapy often face autoimmune reactions, toxicity, and other adverse effects. I think the open FDA webinar, which you can register for, will provide a lot of new information and allow for discussion of key safety issues in gene therapy. I'm going!
Join us for a #virtual listening meeting on 9/20 to share perspectives on safety considerations for approved #GeneTherapy treatments for #RareDiseases and participation in long-term studies after receiving gene therapy. Register to speak by 8/30: https://bit.ly/3XUEQrP
